BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37477758)

  • 1. WTAP Mediates NUPR1 Regulation of LCN2 Through m
    Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
    Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis.
    Sun G; Wang J; Liu F; Zhao C; Cui S; Wang Z; Liu Z; Zhang Q; Xiang C; Zhang Y; Galons H; Yu P; Teng Y
    Biochem Pharmacol; 2024 Apr; 222():116077. PubMed ID: 38395264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUPR1 is a critical repressor of ferroptosis.
    Liu J; Song X; Kuang F; Zhang Q; Xie Y; Kang R; Kroemer G; Tang D
    Nat Commun; 2021 Jan; 12(1):647. PubMed ID: 33510144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
    Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
    Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POU2F2-mediated upregulation of lncRNA
    Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J
    Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting LCN2 can suppress the development of NSCLC by promoting ferroptosis.
    Pan Z; Li B; Lu P; Rong G; Wang X
    Gene; 2024 Feb; 894():148026. PubMed ID: 38000702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
    Song X; Wang X; Chen X; Yu Z; Zhou Y
    J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.
    Chen S; Xia H; Sheng L
    Dig Liver Dis; 2023 Jul; 55(7):967-981. PubMed ID: 36586770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGM5P3-AS1 regulates MAP1LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-negative breast cancer.
    Qi L; Sun B; Yang B; Lu S
    Breast Cancer Res Treat; 2022 Jun; 193(2):305-318. PubMed ID: 35325342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability.
    Valashedi MR; Roushandeh AM; Tomita K; Kuwahara Y; Pourmohammadi-Bejarpasi Z; Kozani PS; Sato T; Roudkenar MH
    Life Sci; 2022 Sep; 304():120704. PubMed ID: 35714703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.
    Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTGER3 knockdown inhibits the vulnerability of triple-negative breast cancer to ferroptosis.
    Wang S; Zhang Y; Zhang D; Meng J; Che N; Zhao X; Liu T
    Cancer Sci; 2024 Jun; 115(6):2067-2081. PubMed ID: 38566528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
    Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
    Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis.
    Zhao Y; Ruan X; Cheng J; Xu X; Gu M; Mueck AO
    Climacteric; 2023 Apr; 26(2):135-142. PubMed ID: 36724820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
    He ZX; Li J; Wang QF; Cheng Q; Ni SJ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
    [No Abstract]   [Full Text] [Related]  

  • 16. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2.
    Cheng G; Sun X; Wang J; Xiao G; Wang X; Fan X; Zu L; Hao M; Qu Q; Mao Y; Xue Y; Wang J
    Cancer Res; 2014 Feb; 74(3):862-72. PubMed ID: 24295734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
    Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer.
    Wang Y; Pang X; Liu Y; Mu G; Wang Q
    Carcinogenesis; 2023 Dec; 44(8-9):708-715. PubMed ID: 37665951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.